上市后11年PMS:见证瑞蓝®改善鼻唇沟的长期效果和安全性

2021-06-02 高德美院 网络

上市后11年PMS:见证瑞蓝®改善鼻唇沟的长期效果和安全性

4a1d41392c8393de17d3e23b7e6f877.png

468330882258f60da0dbcfbabf78472.jpg

 

07a30c98578e4f2414145919623c685.png

参考文献:

1.André P. Evaluation of the safety of a non-animal stabilized hyaluronic acid (NASHA -- Q-Medical, Sweden) in European countries: a retrospective study from 1997 to 2001. J Eur Acad Dermatol Venereol. 2004;18(4):422-425.

2.Weiss R H, Bank D, Brandt F S, et al. Randomized, Double‐Blind, Split‐Face Study of Small‐Gel‐Particle Hyaluronic Acid with and without Lidocaine During Correction of Nasolabial Folds[J]. Dermatologic Surgery, 2010, 36(1): 750-759.

3.Glogau R G, Bank D, Brandt F S, et al. A Randomized, Evaluator‐Blinded, Controlled Study of the Effectiveness and Safety of Small Gel Particle Hyaluronic Acid for Lip Augmentation[J]. Dermatologic Surgery, 2012, 38(7): 1180-1192.

4.Carruthers J, Klein A W, Carruthers A, et al. Safety and Efficacy of Nonanimal Stabilized Hyaluronic Acid for Improvement of Mouth Corners[J]. Dermatologic Surgery, 2005, 31(3): 276-280.

5.Berros P, Lax L, Bétis F. Hyalurostructure treatment: superior clinical outcome through a new protocol-a 4-year comparative study of two methods for tear trough treatment. Plast Reconstr Surg. 2013 Dec;132(6):924e-31e.

6. Gilbert E, Calvisi L. Midface and perioral volume restoration: a conversation between the US and Italy. J Drugs Dermatol. 2014 Jan;13(1):67-74.

7.Yan X, You L, Chen L, et al. [Study on stabilized hyaluronic acid-based gel of non-animal origin for the correction of nasolabial folds].[J]. Chinese journal of plastic surgery, 2009, 25(6): 411-415.

8.杨晓楠,祁佐良,孙家明, 等.透明质酸皮肤填充剂在中国人群中矫正鼻唇沟皱褶的有效性和安全性评价[J].中华整形外科杂志,2019,35(9):922-927.

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2038234, encodeId=0f98203823484, content=<a href='/topic/show?id=3a3a9e011f2' target=_blank style='color:#2F92EE;'>#长期效果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97011, encryptionId=3a3a9e011f2, topicName=长期效果)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85df2500173, createdName=654699882_84926986, createdTime=Mon Nov 01 08:59:48 CST 2021, time=2021-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1047358, encodeId=dccb104e35889, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Wed Jun 02 17:59:48 CST 2021, time=2021-06-02, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2038234, encodeId=0f98203823484, content=<a href='/topic/show?id=3a3a9e011f2' target=_blank style='color:#2F92EE;'>#长期效果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97011, encryptionId=3a3a9e011f2, topicName=长期效果)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85df2500173, createdName=654699882_84926986, createdTime=Mon Nov 01 08:59:48 CST 2021, time=2021-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1047358, encodeId=dccb104e35889, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Wed Jun 02 17:59:48 CST 2021, time=2021-06-02, status=1, ipAttribution=)]
    2021-06-02 CHANGE

    疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的

    0